Citations (38)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Bernard Man Yung Cheung & Shiu-Kum Lam. (1996) Section Review: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Is there a role for antacids in the modern management of peptic ulcers?. Expert Opinion on Investigational Drugs 5:3, pages 345-353.
Read now
Read now
K. Lauritsen & E. Christensen. (1996) The Randomized Controlled Clinical Trial in Gastroenterology: The Danish Contributions from 1970 to 1994. Scandinavian Journal of Gastroenterology 31:sup216, pages 181-198.
Read now
Read now
V. Savarino, G. S. Mela, P. Zentilin, A. Malesci, S. Vigneri, P. Sossai, F. Di Mario, P. Cutela, M. R. Mele & G. Celle. (1993) Circadian Acidity Pattern in Prepyloric Ulcers: A Comparison with Normal Subjects and Duodenal Ulcer Patients. Scandinavian Journal of Gastroenterology 28:9, pages 772-776.
Read now
Read now
G. Bianchi Porro & F. Parente. (1990) Antacids for Duodenal Ulcer: Current Role. Scandinavian Journal of Gastroenterology 25:sup174, pages 48-53.
Read now
Read now
K. Lauritsen. (1989) Relapse of Gastric Ulcers after Healing with Omeprazole and Cimetidine: A Double-Blind Follow-up Study. Scandinavian Journal of Gastroenterology 24:5, pages 557-560.
Read now
Read now
K. Lauritsen, L. Stærk Laursen, T. Havelund, J. Brønnum-Schou & J. Rask-Madsen. (1989) Rioprostil and Ranitidine in the Treatment of Prepyloric Gastric Ulcer: A Double-Blind Comparative Trial. Scandinavian Journal of Gastroenterology 24:3, pages 368-372.
Read now
Read now
K. Lauritsen. (1989) Omeprazole in the Treatment of Prepyloric Ulcer: Review of the Results of the Danish Omeprazole Study Group. Scandinavian Journal of Gastroenterology 24:sup166, pages 54-57.
Read now
Read now
S. J. Konturek, T. Brzozowski, D. Drozdowicz & C. Nauert. (1989) Gastroprotection by an Aluminium- and Magnesium Hydroxide-Containing Antacid in Rats. Scandinavian Journal of Gastroenterology 24:9, pages 1113-1120.
Read now
Read now
P. Bauerfeind, H. R. Koelz & A. L. Blum. (1988) Ulcer Treatment–Regimens and Duration of Inhibition of Acid Secretion: How Long to Dose. Scandinavian Journal of Gastroenterology 23:sup153, pages 23-34.
Read now
Read now
K.-Å. JöNsson, G. Bodemar, K. Norrby, A. Walan, C. Tysk & Ten Other Investigators. (1988) Are Endoscopic and/or Histologic Findings in Gastroduodenal Mucosa a Predictor of Clinical Outcome in Peptic Ulcer Disease?: A 1-Year Follow-up Study after Initial Healing with Either Cimetidine or Medium-Dose Antacid. Scandinavian Journal of Gastroenterology 23:2, pages 199-208.
Read now
Read now
M. Cucala, P. Bauerfeind, C. Emde, J. J. Gonvers, H. R. Koelz & A. L. Blum. (1987) Is it Wise to Prescribe NSAIDs with Modern Gastroprotective Agents?. Scandinavian Journal of Rheumatology 16:sup65, pages 141-154.
Read now
Read now
P. Bytzer, K. Lauritsen & J. Rask-Madsen. (1986) Symptomatic Recurrence of Healed Duodenal and Prepyloric Ulcers after Treatment with Ranitidine or High-Dose Antacid: A 1-Year Follow-up Study. Scandinavian Journal of Gastroenterology 21:6, pages 765-768.
Read now
Read now
M. Ström, A. Berstad, G. Bodemar & A. Walan. (1986) Results of Short- and Long-Term Cimetidine Treatment in Patients with Juxtapyloric Ulcers, with Special Reference to Gastric Acid and Pepsin Secretion. Scandinavian Journal of Gastroenterology 21:5, pages 521-530.
Read now
Read now
M. Ström, G. Bodemar, R. Gotthard & A. Walan. (1986) Duodenal, Prepyloric, and Combined Duodenal/ Prepyloric Ulcer Disease: Three Distinct Entities of Juxtapyloric Ulcer Disease?. Scandinavian Journal of Gastroenterology 21:9, pages 1105-1110.
Read now
Read now
Articles from other publishers (24)
Rena K. Fox & Thiruvengadam Muniraj. (2016) Pharmacologic Therapies in Gastrointestinal Diseases. Medical Clinics of North America 100:4, pages 827-850.
Crossref
Crossref
Andrzej S Tarnawski, Morimasa Tomikawa, Masayuki Ohta & I.James Sarfeh. (2000) Antacid talcid activates in gastric mucosa genes encoding for EGF and its receptor. The molecular basis for its ulcer healing action. Journal of Physiology-Paris 94:2, pages 93-98.
Crossref
Crossref
Susan C. Kalish, Rhonda L. Bohn & Jerry Avorn. (1997) Policy Analysis of the Conversion of Histamine2 Antagonists to Over-the-Counter Use. Medical Care 35:1, pages 32-48.
Crossref
Crossref
W. F. Caspary. 1992. Therapeutische Möglichkeiten bei Erkrankungen des oberen Gastrointestinaltraktes: Antacida im Blickpunkt. Therapeutische Möglichkeiten bei Erkrankungen des oberen Gastrointestinaltraktes: Antacida im Blickpunkt
126
139
.
William R. Garnett & George Earl DukesJr.Jr.. 1992. Applied Therapeutics. Applied Therapeutics
375
396
.
R. L. McISAAC, J. S. DIXON, J. G. MILLS & J. R. WOOD. (2007) Ranitidine in the treatment of duodenal ulcer disease: relationship between antisecretory effect and ulcer healing rate. Alimentary Pharmacology & Therapeutics 5:3, pages 227-243.
Crossref
Crossref
J Mones, I Carrio, M Roca, M Estorch, R Calabuig, S Sainz, C Martinez-Duncker & F Vilardell. (1991) Gastric emptying of two radiolabelled antacids.. Gut 32:2, pages 147-150.
Crossref
Crossref
Karsten Lauritsen, Bent Nyboe Andersen, Laurits Stærk Laursen, Jeppe Hansen, Troels Havelund, Jan Eriksen, Jens F. Rehfeld, Johan Kjærgaard & Jörgen Rask-madsen. (1991) Omeprazole 20 mg three days a week and 10 mg daily in prevention of duodenal ulcer relapse. Gastroenterology 100:3, pages 663-669.
Crossref
Crossref
Stanisław J. Konturek, Tomasz Brzozowski, Danuta Drozdowicz, Artur Dembiński & Christian Nauert. (1990) Healing of chronic gastroduodenal ulcerations by antacids. Digestive Diseases and Sciences 35:9, pages 1121-1129.
Crossref
Crossref
Ramon E. Carpio. (2012) Clinical Efficacy of Low Dose Antacids in the Treatment of Peptic Ulcer. Drug Investigation 2:S1, pages 18-21.
Crossref
Crossref
K. D. BARDHAN, P. MORRIS, R. F. C. HINCHLIFFE, J. H. B. SAUNDERS, B. R. D. MACDOUGALL, J. M. BOLD & P. R. FREEMAN. (2007) A comparison of low-dose maintenance treatment with enprostil against ranitidine in the prevention of duodenal ulcer recurrence. Alimentary Pharmacology & Therapeutics 3:5, pages 489-497.
Crossref
Crossref
Shiu-Kum Lam, Wai-Mo Hui, Matthew M. T. Ng, Anna S. F. Lok, Ching-Lung Lai, Frank Branicki, Wan-Yee Lau & Gar-Pang Poon. (1989) Reducing meal-stimulated acid secretion versus reducing nocturnal acid secretion for healing of duodenal ulcer. Digestive Diseases and Sciences 34:10, pages 1494-1500.
Crossref
Crossref
D Hollander & A Tarnawski. (1989) Are antacids cytoprotective?. Gut 30:2, pages 145-147.
Crossref
Crossref
K. LAURITSEN, B. N. ANDERSEN, T. HAVELUND, L. S. LAURSEN, J. HANSEN, J. ERIKSEN, T. JØRGENSEN & J. RASK‐MADSEN. (2007) Effect of 10 mg and 20 mg omeprazole daily on duodenal ulcer: double‐blind comparative trial. Alimentary Pharmacology & Therapeutics 3:1, pages 59-67.
Crossref
Crossref
Israel Podolsky, Patrick R. Storms, Charles T. Richardson, Walter L. Peterson & John S. Fordtran. (1988) Gastric adenocarcinoma masquerading endoscopically as benign gastric ulcer. Digestive Diseases and Sciences 33:9, pages 1057-1063.
Crossref
Crossref
S.K. Lam. (1988) Antacids: The past, the present, and the future. Baillière's Clinical Gastroenterology 2:3, pages 641-654.
Crossref
Crossref
S Massarrat, H G Muller & P Schmitz-Moormann. (1988) Risk factors for healing of duodenal ulcer under antacid treatment: do ulcer patients need individual treatment?. Gut 29:3, pages 291-297.
Crossref
Crossref
K Lauritsen, S J Rune, H R Wulff, J H Olsen, L S Laursen, T Havelund, L Astrup, F Bendtsen, J Linde & P Bytzer. (1988) Effect of omeprazole and cimetidine on prepyloric gastric ulcer: double blind comparative trial.. Gut 29:2, pages 249-253.
Crossref
Crossref
James W. Freston. (1987) Safety perspectives on parenteral H2-receptor antagonists. The American Journal of Medicine 83:6, pages 58-67.
Crossref
Crossref
Susan J. Cordon, Martin Chatzinoff & Steven R. Peikin. (1987) Medical Care of the Surgical Patient with Gastrointestinal Disease. Medical Clinics of North America 71:3, pages 433-452.
Crossref
Crossref
K Lauritsen, T Havelund, L S Laursen, P Bytzer, J Kjaergaard & J Rask-Madsen. (1987) Enprostil and ranitidine in prevention of duodenal ulcer relapse: one year double blind comparative trial.. BMJ 294:6577, pages 932-934.
Crossref
Crossref
F. HALTER & F. EIGENMANN. (2007) Is it really more difficult to treat prepyloric ulcers?. Alimentary Pharmacology & Therapeutics 1, pages 433s-438s.
Crossref
Crossref
K. LAURITSEN & J. RASK‐MADSEN. (2007) Review: clinical trials in peptic ulcer disease—problems of methodology and interpretation. Alimentary Pharmacology & Therapeutics 1:2, pages 91-123.
Crossref
Crossref
S. K. LAM. (2008) Prostaglandins for duodenal ulcer and gastric ulcer. Journal of Gastroenterology and Hepatology 1:6, pages 471-481.
Crossref
Crossref